Description
7-epi-Docetaxel (4-epi-docetaxel) is an impurity (impurity C) in the synthesis of the cancer therapeutic agent, docetaxel.
Product Unit Size | Cost | Quantity | Stock |
---|
7-epi-Docetaxel (4-epi-docetaxel) is an impurity (impurity C) in the synthesis of the cancer therapeutic agent, docetaxel.
Cas No. | 153381-68-1 |
---|---|
Purity | ≥95% |
Formula | C43H53NO14 |
Formula Wt. | 807.89 |
Chemical Name | [(1S,2S,3R,4S,7R,9R,10S,12R,15S)-4-acetyloxy-1,9,12-trihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate |
IUPAC Name | [(1S,2S,3R,4S,7R,9R,10S,12R,15S)-4-acetyloxy-1,9,12-trihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate |
Synonym | Docetaxel Impurity C, Docetaxel EP Impurity C, 7-Epitaxotere, 5beta,20-Epoxy-1,7alpha,10beta-trihydroxy-9-oxotax-11-ene-2alpha,4,13alpha-triyl 4-acetate 2-benzoate 13-((2R,3S)-3-(((1,1-dimethylethoxy)carbonyl)amino)-2-hydroxy-3-phenylpropanoate); 4-epi-docetaxel. |
Melting Point | 138-140°C |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
JAK2 inhibitor, potential EGFR inhibitor.
Benzimidazole; microtubule polymerization inhib...
Non-depolarizing NMJ blocker; AChR antagonist.<...
CHK1 inhibitor.
Aminoquinoline, binds heme, causes cell lysis.<...
GPR84 agonist.
B-Raf and c-Raf inhibitor.
Centrally acting muscle relaxant.
Synthetic ITC.
Endogenous glycoprotein; lactoferrin agonist.
Sesquiterpene lactone derived from Artemesia; m...
Active metabolite of losartan
NNK precursor found in tobacco smoke; carcinoge...
Thiopurine antimetabolite; PRPP amidotransferas...
Antimicrobial peptide found in amphibians.
Synthetic derivative of selenocyanate.
Isocitrate dehydrogenase inhibitor.
Taxane synthesis intermediate.
Read-through agent and nonsense mutation target...
JNK, ALK, p38 MAPK inhibitor.